116 related articles for article (PubMed ID: 391236)
1. Origin and distribution of 3-methoxy-4-hydroxyphenylglycol in body fluids.
DeMet EM; Halaris AE
Biochem Pharmacol; 1979 Oct; 28(20):3043-50. PubMed ID: 391236
[No Abstract] [Full Text] [Related]
2. On the origin of vanillylmandelic acid and 3-methoxy-4-hydroxy-phenylglycol in the rat brain.
Adèr JP; Muskiet FA; Jeuring HJ; Korf J
J Neurochem; 1978 Jun; 30(6):1213-6. PubMed ID: 670965
[No Abstract] [Full Text] [Related]
3. Distribution and turnover rate of vanillylmandelic acid and 3-methoxy-4-hydroxyphenylglycol in rat brain.
Karoum F; Neff NH; Wyatt RJ
J Neurochem; 1976 Jul; 27(1):33-5. PubMed ID: 956848
[No Abstract] [Full Text] [Related]
4. Concentrations of catecholamines and indoleamines in the central nervous system of Wriggle mouse Sagami.
Kumazawa T; Adachi K; Ando K
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1989; 93(1):167-9. PubMed ID: 2471606
[TBL] [Abstract][Full Text] [Related]
5. Effect of stress on sulfated glycol, metabolites of brain norepinephrine.
Stone EA
Life Sci; 1975 Jun; 16(11):1725-9. PubMed ID: 1142998
[No Abstract] [Full Text] [Related]
6. The effect of acute doses of buprenorphine on concentrations of homovanillic acid (HVA), 5-hydroxyindoleacetic acid (5-HIAA) and 3-methoxy-4-hydroxyphenylglycol (MHPG) in the rat forebrain [proceedings].
Cowan A; Dettmar PW; Walter DS
Br J Pharmacol; 1976 Oct; 58(2):275P. PubMed ID: 974396
[No Abstract] [Full Text] [Related]
7. Acidic and neutral metabolites of norepinephrine: their metabolism and transport from brain.
Meek JL; Neff NH
J Pharmacol Exp Ther; 1972 Jun; 181(3):457-62. PubMed ID: 5033012
[No Abstract] [Full Text] [Related]
8. Chronic treatment with desipramine caused a sustained decrease of 3,4-dihydroxyphenylglycol-sulphate and total 3-methoxy-4-hydroxyphenylglycol in the rat brain.
Nielsen M; Braestrup C
Naunyn Schmiedebergs Arch Pharmacol; 1977 Oct; 300(1):87-92. PubMed ID: 593430
[No Abstract] [Full Text] [Related]
9. Rapid liquid-chromatographic measurement of 3-methoxy-4-hydroxyphenylglycol and other monoamine metabolites in human cerebrospinal fluid.
Langlais PJ; McEntee WJ; Bird ED
Clin Chem; 1980 May; 26(6):786-9. PubMed ID: 6989518
[No Abstract] [Full Text] [Related]
10. Disposition and metabolism of MHPG-CD3 in humans: plasma MHPG as the principal pathway of norepinephrine metabolism and as an important determinant of CSF levels of MHPG.
Kopin IJ; Blombery P; Ebert MH; Gordon EK; Jimerson DC; Markey SP; Polinsky RJ
Adv Biochem Psychopharmacol; 1984; 39():57-68. PubMed ID: 6464833
[No Abstract] [Full Text] [Related]
11. Biochemical aspects of the interaction between midbrain raphe and locus coeruleus in the rat.
Kostowski W; Samanin R; Bareggi SR; Marc V; Garattini S; Valzelli L
Brain Res; 1974 Dec; 82(1):178-82. PubMed ID: 4434214
[No Abstract] [Full Text] [Related]
12. Disposition and metabolism of MHPG in humans: application to studies in depression.
Kopin IJ; Jimerson DC; Markey SP; Ebert MH; Polinsky RJ
Pharmacopsychiatry; 1984 Jan; 17(1):3-8. PubMed ID: 6369349
[TBL] [Abstract][Full Text] [Related]
13. Increased excretion of m-Hydroxyphenylglycol and m-Hydroxymandelic acid in neuroblastoma.
Williams CM; Crowley JR; Couch MW; Midgley JM
Biochem Med; 1982 Dec; 28(3):305-9. PubMed ID: 7165741
[No Abstract] [Full Text] [Related]
14. Studies of amine metabolites in depressed patients. Relationship to suicidal behavior.
Secunda SK; Cross CK; Koslow S; Katz MM; Kocsis JH; Maas JW
Ann N Y Acad Sci; 1986; 487():231-42. PubMed ID: 2436536
[No Abstract] [Full Text] [Related]
15. 3-Methoxy-4-hydroxyphenylglycol sulphate (MOPEG-SO4) as an index of cerebral noradrenaline turnover following depletion of transmitter stores in the rat.
Dolphin A; Jenner P; Marsden CD
J Pharm Pharmacol; 1978 Sep; 30(9):580-2. PubMed ID: 29100
[No Abstract] [Full Text] [Related]
16. Analysis of monoamines in the cerebrospinal fluid of Chinese patients with Alzheimer's disease.
Liu HC; Yang JC; Chang YF; Liu TY; Chi CW
Ann N Y Acad Sci; 1991; 640():215-8. PubMed ID: 1723257
[TBL] [Abstract][Full Text] [Related]
17. Norepinephrine metabolism in man using deuterium labelling: the conversion of 4-hydroxy-3-methoxyphenylglycol to 4-hydroxy-3-methoxymandelic acid.
Mårdh G; Sjöquist B; Anggård E
J Neurochem; 1981 Mar; 36(3):1181-5. PubMed ID: 7205264
[TBL] [Abstract][Full Text] [Related]
18. Reduction of norepinephrine turnover by serotonergic drug in man.
Rudorfer MV; Scheinin M; Karoum F; Ross RJ; Potter WZ; Linnoila M
Biol Psychiatry; 1984 Feb; 19(2):179-93. PubMed ID: 6201198
[TBL] [Abstract][Full Text] [Related]
19. Pathological gambling. A psychobiological study.
Roy A; Adinoff B; Roehrich L; Lamparski D; Custer R; Lorenz V; Barbaccia M; Guidotti A; Costa E; Linnoila M
Arch Gen Psychiatry; 1988 Apr; 45(4):369-73. PubMed ID: 2451490
[TBL] [Abstract][Full Text] [Related]
20. Biogenic amines and depression. The potential value of biochemical parameters in the diagnosis and medication of affective disorders.
Ridges AP
Postgrad Med J; 1976; 52(3 suppl):9-17. PubMed ID: 785425
[No Abstract] [Full Text] [Related]
[Next] [New Search]
